The role of HIV as a risk modifier for coronary endothelial function in young adults

Khaled Z Abd-Elmoniem1, Teja Yeramosu2, Julia B Purdy3

  • 1Biomedical and Metabolic Imaging Branch National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland, USA.

HIV Medicine
|March 30, 2023
PubMed

Insights

People living with HIV have increased cardiovascular disease risk. This study found immune activation and smoking significantly impair coronary endothelial function in young adults with lifelong HIV.

Area of Science:

  • Cardiovascular disease research
  • HIV/AIDS research
  • Immunology

Background:

  • People with HIV (PLWH) face higher cardiovascular disease (CVD) risk.
  • Assessing coronary endothelial function (CEF) directly is challenging.
  • Previous studies used indirect measures in peripheral arteries, yielding conflicting results, and often excluded young adults with lifelong HIV.

Purpose of the Study:

  • To directly investigate CEF in young adults with lifelong HIV.
  • To utilize advanced magnetic resonance imaging (MRI) for precise coronary flow-mediated dilation (corFMD) assessment.
  • To explore the impact of HIV status on coronary vascular health in this unique population.

Main Methods:

  • Employed coronary FMD MRI (corFMD-MRI) with a specialized MRI-integrated isometric handgrip exercise system (fmIHE).
  • Recruited young adults with perinatally/early childhood HIV acquisition (n=23) and matched healthy controls (n=12).
  • Measured corFMD as the change in coronary cross-sectional area during fmIHE.

Main Results:

  • HIV status significantly modified CVD risk.
  • Higher CD8+ T-cell counts and smoking pack-years were independently linked to impaired coronary artery response to fmIHE.
  • In PLWH, corFMD showed an inverse correlation with CD8+ T-cells and smoking pack-years, even after adjusting for age and BMI.

Conclusions:

  • HIV status is a significant risk modifier for CVD in young adults.
  • Immune activation (indicated by CD8+ T-cells) and smoking are associated with reduced CEF in this population.
  • Strategies targeting smoking cessation and immune activation are crucial for managing CVD risk in PLWH.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
39
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
27
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
19
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
19
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.1K